GovernmentPublic CommentVirtual

Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%

Name: Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%
Start: 2026-10-29T23:59:59-04:00

Comments due by Thursday, October 29, 2026

These are formal opportunities to submit a public comment on government rules and proposals — typically in writing through an official portal or by contacting the agency, not in-person speaking slots at a meeting. Check the linked source for the exact submission method and deadline. To give in-person comment at a local meeting, see that body's agenda on its official site.

🎤public comment period

This is a virtual event

Join virtually →

About this event

[Request for Comments] Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%

Event details

Hosting bodyFood and Drug Administration

JurisdictionFederal · United States Government

BranchExecutive

FormatVirtual

Original ListingView original listing ↗

This listing is gathered from a public source and may have changed. Confirm the date, time, location, and other event details with the original source before attending.